Figure 2.
(A) Anecdotal comparison of primary tumor MVD, as estimated by CD34, between 2 DTC patients carrying the ACG+/+ and the CTG+/+ genotypes. High magnification, ×200. (B) Comparison of MVD, as estimated by CD34, in primary tumors from DTC patients carrying the ACG+/+ vs other genotypes. Analysis performed by means of the Mann-Whitney U test. Median, ranges, and confidence intervals are reported for each group.

(A) Anecdotal comparison of primary tumor MVD, as estimated by CD34, between 2 DTC patients carrying the ACG+/+ and the CTG+/+ genotypes. High magnification, ×200. (B) Comparison of MVD, as estimated by CD34, in primary tumors from DTC patients carrying the ACG+/+ vs other genotypes. Analysis performed by means of the Mann-Whitney U test. Median, ranges, and confidence intervals are reported for each group.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close